Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.045; wR factor = 0.119; data-to-parameter ratio = 13.6.
In the cation of the title compound, C 16 H 14 N 3 + ÁCl À Á2H 2 O, the cyclohexa-1,3-diene ring displays a screw-boat conformation and the pyridine ring is slightly twisted with respect to the pyrazole ring with a dihedral angle of 4.56 (12) . In the crystal, ions and water molecules are linked into a three-dimensional network by classical N-HÁ Á ÁO, N-HÁ Á ÁCl, O-HÁ Á ÁCl and O-HÁ Á ÁO hydrogen bonds and by -stacking interactions, with centroid-centroid distances of 3.7580 (14) and 3.7794 (14) Å .
Related literature
For background to the pharmacological properties of indazole derivatives, see: Bistochi et al. (1981) ; Keppler & Hartmann (1994) ; Gomtsyan et al. (2008) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). antitumor (Keppler & Hartmann, 1994) , anti-HIV and analgesic properties (Gomtsyan et al., 2008) . Here, we present the crystal structure determination of the title compound.
The asymmetric unit of the title compound ( Fig. 1) consists of an organic cation, a chloride anion a two lattice water molecules. In the cation, the cyclohexa-1,3-diene ring displays a screw-boat conformation, with atoms C8 and C10 displaced by -0.190 (3) and 0.283 (3) Å, respectively, from the C7/C9/C12/C11 mean plane, and the pyridine ring is twisted to the pyrazole ring by a dihedral angle of 4.56 (12)°. In the crystal structure, cations, anions and water molecule are linked into a three-dimensional network by classical N-H···O, N-H···Cl, O-H···Cl and O-H···O hydrogen bonds (Table 1 ). In addition, π-π stacking interactions [centroid-centroid distances of 3.7580 (14) and 3.7794 (14) Å] extending along the a axis are observed.
A solution of 3,4-dihydronaphthalen-1(2H)-one (1.46 g, 0.01 mol) was added to a stirred solution of hydrazine (0.05 g, 0.01 mol) in dry tetrahydrofuran (50 ml) at 0°C for 3 h, then n-butyllithium (0.02 mol) was added at a fast dropwise rate during a 5 min period. The solution was stirred at 0°C for an additional 30 min, then methyl isonicotinate (1.37 g, 0.01 mol) dissolved in THF (40 ml) was added to the dilithiated intermediate, and the solution was stirred for 60 min at 0°C.
Finally, 20 ml of 3 M hydrochloric acid was added, and the two phase mixture was well stirred and heated under reflux for 45 min. The mixture was then neutralized with solid sodium bicarbonate, and the layers were separated. The aqueous layer was extracted with ether and the organic fractions were combined, evaporated, and the crude product was dissolved in hydrochloric acid (2M, 20 ml). The solution was filtered and the filtrate was set aside for five weeks to obtain colourless crystals. and refined as riding with U iso (H) = 1.5U eq (O). The molecular structure of title compound showing displacement ellipsoids drawn at the 50% probability level. Symmetry codes: (i) x, y, z+1; (ii) x+1, y, z; (iii) −x+1, −y+1, −z.
Computing details

4-(4,5-Dihydro-1H-benzo[g]indazol-3-yl)pyridinium chloride dihydrate
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